0
ARTICLE |

Attitudes Toward Appetite Suppressants: Title and subTitle BreakA Survey of US Physicians FREE

Louis Lasagna, MD
[+] Author Affiliations

Reprint requests to 260 Crittenden Blvd, Rochester, NY 14642 (Dr. Lasagna).


JAMA. 1973;225(1):44-48. doi:10.1001/jama.1973.03220280032008
Text Size: A A A
Published online

A sample of US physicians has been surveyed regarding their opinions about anorexigenic drugs and their prescribing of them. Most physicians see numerous overweight patients, although 22% of the general practitioners, 43% of the obstetrician-gynecologists, and 50% of the internists do not prescribe appetite suppressants for them. Even among physicians who prescribe these drugs, there is wide variation in frequency of prescribing and in opinions regarding their efficacy. Nonamphetamines appear more popular than amphetamines. Only 25% of physicians will prescribe anorexiants for longer than three months. Legitimate prescribing is not seen by US physicians as a serious cause of drug abuse, although they appreciate the hazards of illicit stimulant usage. Most physicians do not wish to see appetite suppressants eliminated from medical use.

REFERENCES

Efforts to prevent dangerous drugs from illicitly reaching the public. Bureau of Narcotics and Dangerous Drugs, US Department of Justice, 1972.
Mellinger GO, Balter MB, Manheimer DI:  Patterns of psychotherapeutic drug use among adults in San Francisco . Arch Gen Psychiatry 25:385-394, 1971;.
Balter M, Levine J:  Character and extent of psychotherapeutic drug usage  in the United States. Read before the Fifth World Congress on Psychiatry , Mexico City, 1971;.
Costa E, Garattini S: International Symposium on Amphetamines and Related Compounds . New York, Raven Press, 1970;.
Cox RH Jr, Maickel RP:  Comparison of anorexigenic and behavioral potency of phenylethylamines . J Pharmacol Exp Ther 181:1-9, 1972;.
Goldberg L:  Epidemiology of drug abuse in Sweden , in Zarafonetis CJ (ed): Proceedings of the International Conference on Drug Abuse . Philadelphia, Lea & Febiger, 1972;, pp 27-66.
Scoville B, Gardner EA:  The FDA review of anorectic drugs: Background, current status, and problem areas . Read before the Symposium on Drugs and the Control of Overweight: Medical Considerations and Public Policy, Washington, DC, 1972 .
Feinstein AR:  The measurement of success in weight reduction: An analysis of methods and a new index . J Chronic Dis 10:439-456, 1959;.
Feinstein AR:  The treatment of obesity: An analysis of methods, results and factors which influence success . J Chronic Dis 11:349-393, 1960;.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Efforts to prevent dangerous drugs from illicitly reaching the public. Bureau of Narcotics and Dangerous Drugs, US Department of Justice, 1972.
Mellinger GO, Balter MB, Manheimer DI:  Patterns of psychotherapeutic drug use among adults in San Francisco . Arch Gen Psychiatry 25:385-394, 1971;.
Balter M, Levine J:  Character and extent of psychotherapeutic drug usage  in the United States. Read before the Fifth World Congress on Psychiatry , Mexico City, 1971;.
Costa E, Garattini S: International Symposium on Amphetamines and Related Compounds . New York, Raven Press, 1970;.
Cox RH Jr, Maickel RP:  Comparison of anorexigenic and behavioral potency of phenylethylamines . J Pharmacol Exp Ther 181:1-9, 1972;.
Goldberg L:  Epidemiology of drug abuse in Sweden , in Zarafonetis CJ (ed): Proceedings of the International Conference on Drug Abuse . Philadelphia, Lea & Febiger, 1972;, pp 27-66.
Scoville B, Gardner EA:  The FDA review of anorectic drugs: Background, current status, and problem areas . Read before the Symposium on Drugs and the Control of Overweight: Medical Considerations and Public Policy, Washington, DC, 1972 .
Feinstein AR:  The measurement of success in weight reduction: An analysis of methods and a new index . J Chronic Dis 10:439-456, 1959;.
Feinstein AR:  The treatment of obesity: An analysis of methods, results and factors which influence success . J Chronic Dis 11:349-393, 1960;.
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.